Cofactor supplementation (thiamine, riboflavin, L-carnitine) ( DrugBank: Riboflavin, Thiamine, Carnitine, L-Carnitine )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 265 | 脂肪萎縮症 | 1 |
265. 脂肪萎縮症
臨床試験数 : 112 / 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00202228 (ClinicalTrials.gov) | July 2002 | 13/9/2005 | Lactate Metabolism Study in HIV Infected Persons | Lactic Acid Metabolism in HIV-Infected Persons. Predicting Abnormalities in Lactate Production and Clearance Related to Treatment and Liver Disease and Measuring the Impact of Vitamin Supplementation. | HIV Infections;AIDS;Lactic Acidosis;Lipodystrophy | Drug: cofactor supplementation (thiamine, riboflavin, L-carnitine) | Queen's University | Ontario HIV Treatment Network | Completed | 18 Years | N/A | Both | 30 | Phase 4 | Canada |